Articles
March 29, 2023
Leading by Example in Gender Diversity Among Executive Leadership
Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.
Read More ›
March 10, 2023
Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics
Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics
Read More ›
March 2, 2023
Alnylam Named One of Fast Company's Most Innovative Companies for 2023
Alnylam is one of Fast Company's Most Innovative Companies for 2023, and is ranked #5 in the Medicines and Therapeutics category.
Read More ›
February 28, 2023
The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disease ...
Rare Disease Day unites the community to spread awareness and support the millions of people worldwide living with with a rare disease.
Read More ›
January 31, 2023
Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row
Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row.
Read More ›
December 8, 2022
Alnylam Named One of America's Most Responsible Companies by Newsweek
Alnylam has been named one of America's Most Responsible Companies for 2023 by Newsweek and research firm Statista
Read More ›
November 30, 2022
Alnylam Named #1 Largest Employer in MA for 2nd Year in a Row by The Boston Globe
Alnylam is a Boston Globe Top Place to Work for the 8th consecutive year and the #1 ranked company on the "Largest Employers" list for the second year in a row
Read More ›
October 26, 2022
Alnylam Named #2 <em>Science Magazine</em> Top Biopharma Employer
Alnylam has been named the #2 Science Magazine Top Biopharma Employer for 2022, which marks our 4th year on the list.
Read More ›
October 24, 2022
“Be the Link!” Learn from patients on World Amyloidosis Day
No one knows this better than Jean-Christophe Fidalgo, President of the Amyloidosis Alliance, who has been living with hATTR amyloidosis for more than 20 years.
Read More ›
September 27, 2022
Alnylam Named a Best Workplace for Women by Fortune Magazine
Alnylam has been named a Fortune Best Workplace for Women for 2022
Read More ›
